In terms of clinical manifestations, AHC is primarily characterized by adrenocortical hormone deficiency and hypogonadotropic hypogonadism (HH), and its molecular pathology typically reveals DAX-1 mutations. This evidence concerns the gene NR0B1 and hypogonadotropic hypogonadism.